Navidea Biopharmaceuticals Inc (NAVB)

[kookiekook]

Whether the sales force are employees of Navidea or Cardinal Health, there are costs associated with them that are or have been paid for by Navidea.

1st Quarter Report 2013 - The net increase was primarily due to increased compensation costs of $434,000 related to increased headcount and incentive-based compensation, increased medical education costs to support Lymphoseek of $290,000

2nd Quarter Report 2013 - Selling, general and administrative expenses increased $1.2 million, or 40%, to $4.2 million during the second quarter of 2013 from $3.0 million during the same period in 2012. The net increase was primarily due to increased medical education costs to support Lymphoseek of $815,000, increased compensation costs of $235,000 related to increased headcount and incentive-based compensation,

3rd Quarter Report 2013 - Selling, general and administrative expenses increased $1.1 million, or 35%, to $4.0 million during the third quarter of 2013 from $2.9 million during the same period in 2012. The net increase was primarily due to increased medical education costs to support Lymphoseek of $749,000

That totals over $1.8million in sales costs for Lymphoseek for the first 9 months of 2013. So while, Cardinal has undoubtedly paid for the bulk of the sales force cost, Navidea has had costs associated with as well. Note: These cost as of the end of the 3rd quarter exceed revenues from Lymphoseek by a margin of 3:1, and account for about 5% of the year-to-date loss.